• / Free eNewsletters & Magazine
  • / My Account
Home>Research & Insights>Investment Insights>In the Performance Race, This Fund Is on the Wrong Track

Related Content

  1. Videos
  2. Articles
  1. Low Volatility vs High Dividend: Which One Is Better?

    Morningstar ETF Invest Conference panelists discuss the similarities, differences, and appeal of these two strategies in today's low-growth, low-return, and high-volatility market.

  2. Going for Growth in U.S. Equities

    Investors' real-return expectations are too high for foreign stocks and too low for U.S. stocks, especially for small- and mid-cap names, says Richard Bernstein, CEO of Richard Bernstein Advisors.

  3. Stock ETFs Worth Sticking Around For

    Although the stock market isn't a screaming buy today, investors shouldn't completely abandon equities for bonds. Here are some stock ETFs that are worth a closer look.

  4. Arnott: Why Cap-Weighted Indexing Is Flawed

    A capitalization-weighted index explicitly links the weight of a holding to its price, so the more expensive a stock gets, the bigger its weight in your portfolio, says Research Affiliates' Rob Arnott.

In the Performance Race, This Fund Is on the Wrong Track

Equal-weighting has merit, but make sure you measure with the proper benchmark.

Michael Rawson, CFA, 06/21/2013

Over the past 10 years, Guggenheim S&P 500 Equal Weight RSP has crushed the S&P 500, returning 9.48% per year compared with 7.23%. However, a quick glance at the Morningstar Style Box should alert investors that this is a poor comparison. The RSP portfolio behaves more like a mid-cap portfolio than the large-cap S&P 500. By that score, RSP has underperformed the S&P MidCap 400 by more than a percent per year. While fund marketers might like to advertise equal-weighting as providing a smarter beta or better diversification, the truth is that it is closer to a bait-and-switch. While the exposure is clearly mid-cap, equal-weighting does generate legitimate alpha from the forced buy low-sell high rebalance strategy. Investors would keep more of this alpha if it weren't for the fund's relatively high expense ratio of 0.40%

A Better Beta
Of all of the non-market-cap-weighted investment strategies, the simplest to conceptualize is equal-weighting. Here, each stock has the same weighting in the portfolio. In the equal-weighted version of the S&P 500 Index, giant caps like Apple AAPL carry the same heft as mid-caps like AutoNation AN, despite the fact that Apple has a market cap more than 200 times larger. Thus, the fund is a better supplement for mid-cap exposure and is best used as a satellite or tactical position rather than a core holding.

Source: Morningstar.

Market-cap-weighted indexes skew toward the largest companies in the index, leading to a concentration in giant-cap names. A full 20% of the S&P 500 is held in just 10 stocks. That concentration gets muted in an equal-weighted fund such as RSP, so that just about 2% of the equal-weighted S&P 500 resides in the top 10 stocks. In essence, the equal-weighted index takes large underweightings in a handful of mega-cap stocks and takes small overweightings in many large- and mid-cap stocks. While some might argue that this lowers concentration risk, those mega-cap names tend to have very low volatility compared with mid-caps.

One way to measure the extent of exposure to smaller-cap stocks is to run a regression model. Regression is a statistical method used to break down returns by source or to analyze risk exposures of a fund. Since 2003, the equal-weighted version of the S&P 500 has had a beta to the traditional Fama-French SMB (small minus big) factor of positive 0.19 while the S&P 500 has a beta of negative 0.15, indicating that it tilts in the opposite direction toward mega-caps.

Still, that regression also reveals that equal-weighting generated an excess return, or alpha, of about 0.11 basis points a month. A paper by Yuliya Plyakha, Raman Uppal, and Grigory Vilkov demonstrates that the source of the alpha in an equal-weighted strategy is the rebalance. But this is for the index. In the real world, RSP has to overcome the expense ratio and trading costs. As a result, RSP investors could only capture an alpha of 0.07% per month or about 0.84% per year.

Is Now the Right Time to Increase Mid-Cap Exposure?
Despite the recent uncertainty, the stock market is near all-time highs. The S&P 500 trades at a price/trailing earnings of about 18.3 times, which is rich compared with historical multiples. Our equity analysts, who assign price/fair value estimates on 98% of the stocks in the index, see those stocks as trading at a price/fair value of 0.98. However, by equal-weighting and putting more emphasis on mid-cap stocks, the price/fair value becomes slightly more expensive at 1.01 times. In addition, these mid-caps are slightly lower quality, with only 19.6% of assets having a wide moat, compared with 43.0% for the S&P 500. The lower moat ratings are reflected in the greater volatility of RSP, 17.8% compared with 14.6% for the S&P 500. Investors in RSP should be prepared to greater volatility than they would have in the S&P 500.

Even after a sober look, we like the equal-weighted strategy. But at 0.40%, it is difficult to recommend RSP. This was one of the first strategy ETFs to launch, and its expense ratio does not reflect today's competitive landscape. The methodology is fairly simple and does not require a black-box model, but RSP has lagged its benchmark by more than its expense ratio, indicating high trading costs or poor execution.

Disclosure: Morningstar, Inc.’s Investment Management division licenses indexes to financial institutions as the tracking indexes for investable products, such as exchange-traded funds, sponsored by the financial institution. The license fee for such use is paid by the sponsoring financial institution based mainly on the total assets of the investable product. Please click here for a list of investable products that track or have tracked a Morningstar index. Neither Morningstar, Inc. nor its investment management division markets, sells, or makes any representations regarding the advisability of investing in any investable product that tracks a Morningstar index. 

Michael Rawson, CFA is an ETF Analyst with Morningstar.
blog comments powered by Disqus
Upcoming Events

©2014 Morningstar Advisor. All right reserved.